An Exploratory Clinical Study of CDK4/6i Dalpiciclib Combined With AI Neoadjuvant Therapy for Stage II-III HR+/HER2- Breast Cancer
Clinical trial NCT06613373 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06613373
- Sponsor
- Jiangsu Famous Medical Technology Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-15
- Primary completion
- 2025-10-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.